Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN ASSOCIATION FOR CANCER RESEARCH via AMERICAN ASSOCIATION FOR CANCER RESEARCH
2026 · third_quarter · Q3
Tobacco control and prevention Tobacco cessation
Cancer research generally Diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention
Source: Senate LDA
FY 2027 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts. OMB proposed rule on revisions to the Uniform Guidance.
Reducing cancer disparities Cancer survivorship
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION FOR CANCER RESEARCH via AMERICAN ASSOCIATION FOR CANCER RESEARCH
2026 · second_quarter · Q2
Tobacco control and prevention Tobacco cessation
Reducing cancer disparities Cancer survivorship
Cancer research generally Diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention
FY 2027 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION FOR CANCER RESEARCH via AMERICAN ASSOCIATION FOR CANCER RESEARCH
2026 · first_quarter · Q1
FY 2027 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.
Reducing cancer disparities Cancer survivorship Preventing HPV-related cancers
Cancer research generally Diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention
Tobacco control and prevention Tobacco cessation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION FOR CANCER RESEARCH via AMERICAN ASSOCIATION FOR CANCER RESEARCH
2025 · fourth_quarter · Q4
FY 2026 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.
Cancer research generally Diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention
Tobacco control and prevention Tobacco cessation
Reducing cancer disparities Cancer survivorship Preventing HPV-related cancers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION FOR CANCER RESEARCH via AMERICAN ASSOCIATION FOR CANCER RESEARCH
2025 · third_quarter · Q3
FY 2026 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.
Cancer research generally Increasing diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention
Tobacco control and prevention Tobacco cessation
Reducing cancer disparities Cancer survivorship Preventing HPV-related cancers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION FOR CANCER RESEARCH via AMERICAN ASSOCIATION FOR CANCER RESEARCH
2025 · second_quarter · Q2
FY 2026 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.
Cancer research generally Increasing diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention
Tobacco control and prevention Tobacco cessation
AMERICAN ASSOCIATION FOR CANCER RESEARCH via AMERICAN ASSOCIATION FOR CANCER RESEARCH
2025 · first_quarter · Q1
FY 2025 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.
Cancer research generally Increasing diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention
Tobacco control and prevention Tobacco cessation
AMERICAN ASSOCIATION FOR CANCER RESEARCH via AMERICAN ASSOCIATION FOR CANCER RESEARCH
2024 · fourth_quarter · Q4
Cancer research generally Increasing diversity in clinical trials Drug approval Pediatric cancer detection, treatment, and prevention
Reducing cancer disparities Cancer survivorship Preventing HPV-related cancers
Tobacco control and prevention Tobacco cessation
AMERICAN ASSOCIATION FOR CANCER RESEARCH via AMERICAN ASSOCIATION FOR CANCER RESEARCH
2010 · second_quarter · RA
Funding for NIH, CDC, FDA Cancer research, clinical trials, diversity in clinical trials, pediatric research and cancer care, oncology product review at FDA Tobacco control measures, e-cigarette regulation Cancer health disparities, cancer survivorship, HPV vaccination, HPV-related cancers NIH reform
Funding for NIH, CDC, FDA Cancer research, clinical trials, diversity in clinical trials, pediatric research and cancer care, oncology product review at FDA Tobacco control measures, e-cigarette regulation Cancer health disparities, cancer survivorship, HPV vaccination, HPV-related cancers NIH reform
Reducing cancer disparities Cancer survivorship Preventing HPV-related cancers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Reducing cancer disparities Cancer survivorship Preventing HPV-related cancers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2025 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Funding for NIH, CDC, FDA Cancer research, clinical trials, diversity in clinical trials, pediatric research and cancer care, oncology product review at FDA Tobacco control measures, e-cigarette regulation Cancer health disparities, cancer survivorship, HPV vaccination, HPV-related cancers NIH reform
Funding for NIH, CDC, FDA Cancer research, clinical trials, diversity in clinical trials, pediatric research and cancer care, oncology product review at FDA Tobacco control measures, e-cigarette regulation Cancer health disparities, cancer survivorship, HPV vaccination, HPV-related cancers NIH reform